Showing results (301-310 of 364) with videos related to
Sort By:
Pageof 37
Bioorganic & Medicinal Chemistry|December 21, 2010
Design, synthesis and biological evaluation of small molecule inhibitors of CD4-gp120 binding based on virtual screeningJudith M Lalonde, Mark A Elban, Joel R Courter, et al.Organic Letters|January 28, 2005
Design, synthesis, and binding affinities of pyrrolinone-based somatostatin mimeticsAmos B Smith, Adam K Charnley, Eugen F Mesaros, et al.Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors possessing augmented P2' side chainsAmos B Smith, Adam K Charnley, Hironori Harada, et al.Proceedings of the National Academy of Sciences of the United States of America|March 31, 2004
Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteinsZhihai Si, Navid Madani, Jason M Cox, et al.Journal of Medicinal Chemistry|May 2, 2003
Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitorsAmos B Smith, Louis-David Cantin, Alexander Pasternak, et al.Journal of Virology|December 23, 2016
Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed InhibitorsBeatriz Pacheco, Nirmin Alsahafi, Olfa Debbeche, et al.Journal of Medicinal Chemistry|May 23, 2017
Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative DiseasesAnne-Sophie Cornec, Ludovica Monti, Jane Kovalevich, et al.Journal of Virology|August 9, 2019
Strain-Dependent Activation and Inhibition of Human Immunodeficiency Virus Entry by a Specific PF-68742 StereoisomerConnie Zhao, Amy M Princiotto, Hanh T Nguyen, et al.ACS Medicinal Chemistry Letters|January 19, 2023
Structural and Functional Characterization of Indane-Core CD4-Mimetic Compounds Substituted with Heterocyclic AminesCheyenne Chaplain, Christopher J Fritschi, Saumya Anang, et al.Molecular Pharmacology|April 12, 2008
Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin LParag P Shah, Michael C Myers, Mary Pat Beavers, et al.Pageof 37